| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |